SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Clinical trial NCT04282070 · UNKNOWN

Trial details

NCT number: NCT04282070
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2020-03-27
Primary completion: 2022-04-16
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.